Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus.
Wambier
Carlos G
CG
Foss-Freitas
Maria C
MC
Paschoal
Renato S
RS
Tomazini
Marilia V
MV
Simão
João C
JC
Foss
Milton C
MC
Foss
Norma T
NT
D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007074:Immunoglobulin G / Q000009:adverse effects*; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept